APA (7th ed.) Citation

AY, A., NR, K., M, P., W, M., LK, H., AA, S., . . . ZH, M. (2025). Anti-muscarinic 3 antibodies associate with a severe clinical phenotype in patients with systemic sclerosis. Rheumatology (Oxford, England), 64(10), 5230. https://doi.org/10.1093/rheumatology/keaf197

Chicago Style (17th ed.) Citation

AY, Ayla, Kalavar NR, Pimentel M, Morales W, Hummers LK, Shah AA, Hughes M, and McMahan ZH. "Anti-muscarinic 3 Antibodies Associate with a Severe Clinical Phenotype in Patients with Systemic Sclerosis." Rheumatology (Oxford, England) 64, no. 10 (2025): 5230. https://doi.org/10.1093/rheumatology/keaf197.

MLA (9th ed.) Citation

AY, Ayla, et al. "Anti-muscarinic 3 Antibodies Associate with a Severe Clinical Phenotype in Patients with Systemic Sclerosis." Rheumatology (Oxford, England), vol. 64, no. 10, 2025, p. 5230, https://doi.org/10.1093/rheumatology/keaf197.